July 26, 2017 7:40 AM ET


Company Overview of Laboratorios Litaphar S.A.

Company Overview

Laboratorios Litaphar, S.A. develops generic medicines and pharmaceutical products through bioequivalence research and elaboration. The company’s products include Enalapril APHAR, Omeprazol APHAR, Claritromicina APHAR, Lovastatina APHAR, and Furosemida APHAR for treatment of hypertension, cardiac insufficiency, gastric and duodenal ulcers, respiratory tract infections, and skin infections. The company was founded in 2001 and is based in Azpeitia, Spain with an additional office in Madrid, Spain. As of May 19, 2006, Laboratorios Litaphar S.A. operates as a subsidiary of Reddy Pharma Iberia, S.A.

C/ Orendaundi, 9

Azpeitia,  20730


Founded in 2001


34 902 99 97 71


34 902 99 98 81

Key Executives for Laboratorios Litaphar S.A.

Laboratorios Litaphar S.A. does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
Ability Pharmaceuticals, S.L. Europe
Activery Biotech SL Europe
Aelix Therapeutics SL Europe
AlbaJuna Therapeutics SL Europe
Alcaliber S.A. Europe

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
The Advertising Council, Inc. United States
Bertelsmann AG Europe
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Laboratorios Litaphar S.A., please visit www.litaphar.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.